Results 131 to 140 of about 16,340 (253)

Holmium-166 Radioembolization

, 2023
During the last decade, the use of holmium-166 (166Ho) microspheres as radioembolization device has been increasing throughout Europe. Chapter 1 presented the use of 166Ho microspheres as an alternative to 90Y for radioembolization, during the scout and the treatment, describing the steps involved in the clinical workflow. 166Ho imaging possibilities,
openaire   +2 more sources

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Journal of Clinical Interventional Radiology ISVIR
Purpose The aim of this study is to report the early outcomes of holmium-166 (166Ho) radioembolization in the treatment of liver metastases.
Murat Dökdök, Kezban Berberoğlu
doaj   +1 more source

Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? [PDF]

, 2010
Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10-15% of HCC patients are suitable candidates for hepatic resection and liver transplantation due to the advanced ...
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch   +5 more
core   +2 more sources

Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management

Current Oncology
Neuroendocrine tumors (NETs) are a heterogeneous class of cancers, predominately occurring in the gastroenteropancreatic system, which pose a growing health concern with a significant rise in incidence over the past four decades.
Cody R. Criss, Mina S. Makary
doaj   +1 more source

Hepatocellular carcinoma [PDF]

, 2018
Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer.
Gores, Gregory, Llovet i Bayer, Josep Maria, Pikarsky, Eli, Sangro, Bruno, Schwartz, Myron, Sherman, Morris, Zucman-Rossi, Jessica   +6 more
core   +1 more source

Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization

Frontiers in Oncology
PurposeThe purpose of this study is to elucidate the patterns of recurrence of hepatocellular carcinoma and to analyze factors that can predict recurrence after complete response to radioembolization.Materials and methodsA total of 289 consecutive ...
Sungmo Moon, Gyoung Min Kim, Jong Yun Won, Joon Ho Kwon, Juil Park, Kichang Han, Man-Deuk Kim, Hyung Cheol Kim, Dong Kyu Kim, Jin Young Choi   +9 more
doaj   +1 more source

Intermediate hepatocellular carcinoma: current treatments and future perspectives [PDF]

, 2017
Current guidelines recommend transarterial chemoembolization (TACE) as the standard treatment of Barcelona-Clinic Liver Cancer (BCLC)-B patients. However, the long-term survival outcomes of patients managed with this technique do not appear fully ...
Bargellini, I., De Maria, N., De Simone, P., Dufour, J.-F, Goulis, I., Marinho, R. T.   +5 more
core  

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

Frontiers in Medicine, 2019
Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h physical half-life, which has been shown to be a very attractive candidate for use in therapeutic nuclear medicine.
Nicolas Lepareur, Nicolas Lepareur, Franck Lacœuille, Franck Lacœuille, Christelle Bouvry, Christelle Bouvry, François Hindré, François Hindré, Emmanuel Garcion, Emmanuel Garcion, Michel Chérel, Michel Chérel, Nicolas Noiret, Nicolas Noiret, Etienne Garin, Etienne Garin, F. F. Russ Knapp   +16 more
doaj   +1 more source

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma

Journal of Clinical Medicine, 2019
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and affects millions worldwide. Due to the lack of effective systemic therapies for HCC, researchers have been investigating the use of locoregional tumor control with Yttrium-
A. Saini, A. Wallace, S. Alzubaidi, M. Knuttinen, S. Naidu, R. Sheth, H. Albadawi, R. Oklu   +7 more
semanticscholar   +1 more source

The Essential Role of Monte Carlo Simulations for Lung Dosimetry in Liver Radioembolization—Part B: ¹⁶⁶Ho Microspheres

Applied Sciences
This study compares dosimetric approaches for lung dosimetry in 166 radioembolization (Ho-TARE) with direct Monte Carlo (MC) simulations on a voxelized anthropomorphic phantom derived from a real patient’s CT scan, preserving the patient’s lung density ...
Edoardo d’Andrea, Andrea Politano, Bartolomeo Cassano, Nico Lanconelli, Marta Cremonesi, Vincenzo Patera, Massimiliano Pacilio   +6 more
doaj   +1 more source